Legal Representation
Attorney
Brian O'Donnell
USPTO Deadlines
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 17, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 16, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 16, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 16, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 16, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 5, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 27, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 12, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 12, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Mar 12, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 12, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 12, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 12, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 18, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Dec 18, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, compounds in a unitary solid dosage form made by a three-dimensional printing process for the rapid dispersion of a wide variety of therapeutic agents
Class 040
Pharmaceutical manufacturing to the order and/or specification of others
Class 042
Development of pharmaceutical and nutraceutical preparations for others; research and development in the pharmaceutical and nutraceutical fields for others; Consulting services in the field of biotechnology in the development of pharmaceutical and nutraceutical preparations in the nature of drug delivery systems
Class 044
Medical and pharmaceutical consultancy, namely, pharmaceutical advice about drug delivery systems
Additional Information
Design Mark
The mark consists of a letter "A" in stylized font with the word "APRECIA" to the right of the letter "A".
Classification
International Classes
005
040
042
044